| Literature DB >> 35170010 |
Carla Fabrine Carvalho1, Julio Cesar Teixeira1, Joana Froes Bragança1, Sophie Derchain1, Luiz Carlos Zeferino1, Diama Bhadra Vale1.
Abstract
The present update is a reassessment of the 2018 'Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil' (Zeferino et al.)9, according to the changes observed in new international guidelines and knowledge updates. The most relevant and recent guidelines were assessed. Questions regarding the clinical practice were formulated, and the answers considered the perspective of the public and private sectors of the Brazilian health system. The review addressed risk-based strategies regarding age to start and stop screening, the use of cytology and colposcopy to support management decisions, treatment, follow-up strategies, and screening in specific groups, including vaccinated women. The update aims to improve the prevention of cervical cancer and to reduce overtreatment and the misuse of HPV testing. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).Entities:
Mesh:
Year: 2022 PMID: 35170010 DOI: 10.1055/s-0041-1739314
Source DB: PubMed Journal: Rev Bras Ginecol Obstet ISSN: 0100-7203